tiprankstipranks
Trending News
More News >
Iridex Corp (IRIX)
NASDAQ:IRIX
US Market
Advertisement

Iridex (IRIX) Price & Analysis

Compare
132 Followers

IRIX Stock Chart & Stats


Iridex News

IRIX FAQ

What was Iridex Corp’s price range in the past 12 months?
Iridex Corp lowest stock price was $0.78 and its highest was $1.95 in the past 12 months.
    What is Iridex Corp’s market cap?
    Iridex Corp’s market cap is $19.54M.
      When is Iridex Corp’s upcoming earnings report date?
      Iridex Corp’s upcoming earnings report date is Nov 18, 2025 which is in 47 days.
        How were Iridex Corp’s earnings last quarter?
        Iridex Corp released its earnings results on Aug 12, 2025. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.06.
          Is Iridex Corp overvalued?
          According to Wall Street analysts Iridex Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Iridex Corp pay dividends?
            Iridex Corp does not currently pay dividends.
            What is Iridex Corp’s EPS estimate?
            Iridex Corp’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Iridex Corp have?
            Iridex Corp has 16,992,252 shares outstanding.
              What happened to Iridex Corp’s price movement after its last earnings report?
              Iridex Corp reported an EPS of -$0.06 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.231%.
                Which hedge fund is a major shareholder of Iridex Corp?
                Currently, no hedge funds are holding shares in IRIX

                Company Description

                Iridex Corp

                IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

                Iridex (IRIX) Earnings & Revenues

                IRIX Earnings Call

                Q2 2025
                0:00 / 0:00
                Earnings Call Sentiment|Neutral
                The earnings call reflected a mix of positive revenue growth and significant cost reductions alongside challenges such as declining gross margins and regional sales issues. The company's successful implementation of efficiency measures and positive adjusted EBITDA were tempered by ongoing market challenges and a net loss.View all IRIX earnings summaries
                Similar Stocks
                Company
                Price & Change
                Follow
                Accelerate Diagnostics
                Lifeward
                Streamex
                Adagio Medical Holdings
                Inspira Technologies Oxy BHN

                Ownership Overview

                5.88%4.10%8.00%78.99%
                8.00% Other Institutional Investors
                78.99% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis